Posted by: Process Matters Blogger on: January 18, 2010
A recent study from IDC shows that pharmaceutical manufacturers will lose an estimated 11 billion dollars through channel inefficiencies this year.
According to the corresponding release this number is “the equivalent to total revenue for a top 20 pharma simply disappearing each year.”
The culprit? Revenue leakage.
According to the release, one of the major sources of revenue leakage, which costs pharmaceutical companies 4.4% of their overall revenue per year, is chargeback discrepancies. The release also states that “63% of manufacturers believe chargeback-related revenue leakage is a serious problem. This is up nearly 25% from a similar survey in 2006.”
With these staggering numbers it is very apparent that pharmaceutical companies have a huge problem on their hands. Fortunately, there are technologies available that can alleviate revenue leakage, and help these companies realize significant ROI along the way.
For example—one of America’s largest pharmaceutical services companies, which ranks among the Fortune 25, has utilized the functionality of Metastorm BPM® to streamline and automate its contracts management and chargeback processes as well as over 175 other process across the enterprise, enabling it to:
With the help of Metastorm BPM, these and many other benefits have been realized, enabling this company to achieve an exponential return on its investment, and helping it to avoid revenue leakage from poor process management.
Want to know more? Watch this customer video testimonial, and read this solution sheet.
You can also check out the Solutions for Life Sciences page on our website.
Related posts:
Related posts brought to you by Yet Another Related Posts Plugin.